EXELIXIS INC
EXEL·30161Q104·US·Common Stock·Healthcare - Biotechnology-Activist
EXEL (EXELIXIS INC) is held by 246 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.3B), RENAISSANCE TECHNOLOGIES LLC ($588.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($562.3M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 123 funds bought EXEL.
246
Holders
(24 Elite)
$9.7B
Total Value
51% (241)
Consensus
123 buying - 118 selling
13F: Insider & Congress:
Who's Trading
InsiderFCFreire Maria CExercise 21K shMay 7, 2026
InsiderPGPOSTE GEORGESell $2.7MMay 7, 2026
InsiderFCFreire Maria CSell $949KMay 7, 2026
InsiderBCBeckerle Mary CExercise 4K shMay 7, 2026
InsiderBCBeckerle Mary CSell $374KMay 7, 2026
InsiderMMMORRISSEY MICHAELGift 110K shMay 6, 2026
InsiderADAftab DanaSell $2.1MFeb 24, 2026
Top Holders
Showing 1-20 of 256
1 / 13
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer